BioCision Inks $2.5M

BioCision, a Larkspur, Calif.-based developer of sample standardization tools for life science research, has raised $2.5 million in debt and equity financing, the company announced Tuesday. BroadOak Capital Partners led the round, with participation from Research Corporation Technologies. The funds will help bolster sales, marketing and development efforts.

5 December 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail